Recombinant factor C (rFC): the animal-free endotoxin test

What is factor C?

Horseshoe crab blood cells contain a chain of enzymes that react to bacterial endotoxin and end in a clot. Factor C is the first link. When endotoxin is present, it activates factor C, which then switches on the next enzymes in the cascade (Innate Immunity, PMC).

The classic endotoxin test, LAL, uses a lysate of those crab blood cells, so it carries the whole cascade. The LAL test method page describes how it is run.

What makes recombinant factor C different from LAL?

Recombinant factor C is made from the cloned factor C gene rather than harvested from crabs. The reagent pairs that enzyme with a fluorogenic substrate: activated factor C cuts the substrate, and the light it gives off is measured (Innate Immunity, PMC). There is no clot and no cascade, only the first step read directly.

That design has one practical consequence for reading results. Natural lysate also contains factor G, a second enzyme that reacts to (1,3)-beta-D-glucan, a component of fungal cell walls (Limulus test review, PMC). Glucan can therefore push an LAL result up even when it is not endotoxin. An rFC reagent has no factor G, so glucan cannot produce that false positive (Microorganisms, 2024).

Why does rFC exist?

Supply and conservation. LAL depends on catching and bleeding wild horseshoe crabs, and the authors of one review argue that harvesting cannot keep up with global demand (Innate Immunity, PMC). A recombinant reagent can be produced without crabs. A 2024 study of rFC on biopharmaceutical products frames it the same way, as answering both ethical concerns and supply limits (Microorganisms, 2024).

Is an rFC result as valid as an LAL result?

It can be, when the method has been shown to work for that kind of sample. The US FDA allows alternative endotoxin methods if they are validated and shown to achieve equivalent or better results than the compendial test; in a dispute, the compendial gel-clot method decides unless a monograph says otherwise (FDA guidance). The same 2024 study notes that rFC is listed as a compendial method in the European Pharmacopoeia and concludes that validation should take the components of each product into account (Microorganisms, 2024).

For a reader, this means the label "rFC" is not a weaker or a stronger result by itself. What matters is the same as for any endotoxin line: a named method, a number with a unit, and a stated limit. The lesson on how labs get it wrong covers why method suitability matters.

How does rFC appear on a certificate?

• The method line may say "recombinant factor C", "rFC", "recombinant reagent" or name a fluorescence assay.
• The result is in endotoxin units, usually per milligram or per millilitre, exactly as an LAL result would be.
• A "less than" value means below what the test could report at that dilution, not zero.
• A line that names rFC but gives no unit or limit has the same gap as an LAL line with no unit or limit.

What does an rFC result not tell you?

The FDA notes that where non-endotoxin pyrogens may be present, a test that detects pyrogens more broadly can be more appropriate (FDA guidance). See endotoxin, pyrogen and the monocyte activation test for those neighbouring terms.